Short of breath: respiratory conditions

With better treatments than ever, why don’t patients with respiratory conditions show better outcomes as well?

New Zealand model of OTC sildenafil earns praise

A small study has investigated community pharmacist attitudes to the over-the-counter (OTC) supply of sildenafil in New Zealand, finding it has enhanced their primary...

Environmentally responsible inhaled respiratory treatments – Implications for practice

Ziqi is a regular at your pharmacy. She has popped in today to purchase a salbutamol pressurised metered dose inhaler (pMDI). You notice on her dispensing history that this will be her third in the last 4 weeks and she is overdue to have her repeat for her budesonide dry powder inhaler (DPI) filled.

Infographic: Here’s how many people pharmacists have vaccinated

So far, community pharmacists have administered enough COVID-19 vaccine doses to fully vaccinate more than 1 million people. But that's just a number – here's what it really looks like.

Advancing dementia care in pharmacy

The various dementias are a huge cause of death in Australia. Despite some light on the horizon, there are still no effective treatments.

Insomnia: a home medicines review case study

Pharmacists have an important role to play in the management of insomnia, including recommending non-pharmacological management.